Role of genetic variation in the human sodium–glucose cotransporter 2 gene (SGLT2) in glucose homeostasis

Author： Enigk Uta   Breitfeld Jana   Schleinitz Dorit   Dietrich Kerstin   Halbritter Jan   Fischer-Rosinsky Antje   Enigk Beate   Müller Ines   Spranger Joachim   Pfeiffer Andreas   Stumvoll Michael   Kovacs Peter   Tönjes Anke  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.8, 2011-08, pp. : 1119-1126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes

By Boyle Luke D   Wilding John PH  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 3, 2013-09 ,pp. : 375-391

Informa Healthcare

Access to resources Recommend Favorite

Sodium glucose co-transporter 2 (SGLT2) inhibitors: novel antidiabetic agents

By Washburn William N  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 483-494

Informa Healthcare

Access to resources Recommend Favorite

Sodium glucose co-transporter 2 (SGLT2) inhibitors as potential antidiabetic agents

By Handlon Anthony L  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 11, 2005-11 ,pp. : 1531-1540

Informa Healthcare

Access to resources Recommend Favorite

Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for New Anti-Diabetic Agent

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 4, 2010-03 ,pp. : 411-418

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of 6-Deoxydapagliflozin as a Highly Potent Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

By  

Medicinal Chemistry, Vol. 10, Iss. 3, 2014-05 ,pp. : 304-317

Bentham Science Publishers

Access to resources Recommend Favorite